type here...

CATEGORIES

Pharmaceutics

LATEST

1...91011Page 10 of 11

TRENDING

EDITORS CHOICE

It’s Time to Up Our Messaging Game Ahead of Another Winter with COVID

Richard Hatzfeld -
This is not the time to roll out stale messaging delivered by a carousel of health officials trying to convince the public to get the test kits.

Mixing Covid Vaccines May Not Be a Great Idea, Research Shows

Medika Life -
Research from, Oxford's Com-Cov study highlights how mixing vaccine brands during follow-up covid vaccinations increases the risk of mild to moderate side effects.

Azithromycin

Medika Life -
Azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

Medika Life -
Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories